Pulmonary hypertension in sickle cell disease (SCD) is a complex phenomenon resulting from multiple overlapping etiologies, including pulmonary vasoconstriction in the setting of chronic hemolytic anemia, diastolic dysfunction, and chronic thromboembolic
Kadija Hersi +6 more
doaj +1 more source
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are two of the key subgroups of pulmonary hypertension. They are characterised by different risk factors.
M. Humbert
doaj
Chronic Thromboembolic Pulmonary Hypertension: A Narrative Review. [PDF]
Jurth T, Marasco S.
europepmc +1 more source
Lung transplantation for chronic thromboembolic pulmonary hypertension. [PDF]
Godinas L +6 more
europepmc +1 more source
Pulmonary Circulation with Chronic Thromboembolic Pulmonary Hypertension
Fukamachi, Daisuke, Okumura, Yasuo
openaire +2 more sources
Prognostic Value of Acute Vasoreactivity in Chronic Thromboembolic Pulmonary Hypertension. [PDF]
Uphus JAG +10 more
europepmc +1 more source
Correction to: Anticoagulation in chronic thromboembolic pulmonary hypertension: an updated systematic review and meta-analysis. [PDF]
Catalani F +7 more
europepmc +1 more source
The Surgical Management of Chronic Thromboembolic Pulmonary Hypertension. [PDF]
McGann KC +12 more
europepmc +1 more source
Understanding the Impact of Hypoxia on Pulmonary Artery Endothelial Cells in Chronic Thromboembolic Pulmonary Hypertension Patients. [PDF]
Roger Y +17 more
europepmc +1 more source
Current Perspectives on Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. [PDF]
Kook H +7 more
europepmc +1 more source

